article thumbnail

International Cannabis Brand Cookies Launches New Product Combining Non-Psychedelic Mushrooms and THC

Cannabis Law Report

BED HEAD: Mushroom + THC Nighttime formulation consists of a five-in-one mushroom blend of Chaga, Maitake, Reishi, Shiitake, and Turkey Tail with a measured dose of THC, CBN, cannabis-derived terpenes and all-natural valerian root to promote relaxation and restful, restorative sleep. Julie Dietel. Grasslands: A Journalism-Minded Agency.

THC 52
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

At the time of Samantha Miller’s summit in 2011, THC was the sole chemical “face” of the plant. Mr. Gardner, the writer whose CBD advocacy eventually inspired the 2011 summit at Ms. In June of 2010, the host of the 2011 summit, the biochemist Ms. Kerr told me, talking about the night at Ms. But the research wasn’t enough.

CBD 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

“There’s everything from people being dosed without their consent, to people being encouraged to sleep with practitioners in exchange for services, to people being pressured to participate in group contexts, and so-called rituals that they otherwise wouldn’t have engaged in.” ” Underground researcher.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Healing Advocacy Fund. In 2020, he co-founded New Yorkers for Mental Health Alternatives, an advocacy group dedicated to psychedelic law reform in New York.

article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

27 There is moderate evidence for the use of cannabinoids for sleep and limited evidence for use in psychiatric conditions, such as post-traumatic stress disorder, depression, anxiety, and psychosis; appetite stimulation and weight gain; and no evidence for cancer treatment. Moderate evidence exists for the use of cannabis for sleep.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

2015 ; Kaiser 2011 ; Mortensen et al. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. Many question whether the cart has been put before the horse; whether legislative change has been driven by the passionate campaigns of patients and advocacy groups rather than evidence-based medicine.

article thumbnail

Minorities in cannabis, with Steven Philpott Jr.

The Cannigma

We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. Until I joined the military, actually, I was part of the longest deployment since World War Two, back in 2011, 2012. Is this as needed for sleep? EG: All right, so that’s going to be straight up to the interview.